Finance News

Shares making the most important strikes forward of the market: Exxon Mobil, Pfizer, Peloton, and others

Before the doorbell rings, check out the companies that are making the headlines:

Exxon Mobil (XOM) – The energy giant announced it was posting a fourth straight quarterly profit, largely thanks to stronger oil and gas prices. The snapshot of the fourth quarter results was released in an SEC filing prior to the official February 1 results.

Advanced Micro Devices (AMD) – The chipmaker now expects a $ 35 billion acquisition of all shares in the first quarter of 2022, with companies saying they haven't received all of the required approvals. Xilinx lost 2.2% in the premarket.

Pfizer (PFE) – UK regulators have approved the use of Paxlovid – the drug company's Covid-19 antiviral pill – for people over 18 with mild to moderate illness.

Peloton (PTON) – The fitness equipment maker lost 1.3% ahead of its IPO after JMP Securities downgraded its stock from “Market Above Average” to “Market Performance”. JMP reports declining website visits and page views.

Colfax (CFX) – The medical technology company is planning a shareholders' meeting to approve a reverse stock split, with the exact ratio to be determined at a later date. Colfax lost 2.7% in pre-trading.

MP Materials (MP) – The rare earth materials maker has filed a shelf issue of up to $ 2 billion in debt. The MP share lost 1.1% before the market.

Lexicon Pharmaceuticals (LXRX) – The drug maker’s shares rose 6.5% in pre-market trading after filing a new drug application with the FDA for its heart drug sotagliflozin, which is believed to reduce the risk of heart failure in diabetics.

Related Articles